Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Treatment of stress urinary incontinence using polyacrylamide hydrogel in women after radiotherapy: 1-year follow-up

J. Krhut, A. Martan, M. Jurakova, D. Nemec, J. Masata, P. Zvara,

. 2016 ; 27 (2) : 301-305. [pub] 20150905

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu klinické zkoušky kontrolované, časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17001022

Grantová podpora
NT13509 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje Online Plný text

NLK ProQuest Central od 1997-01-01 do 2017-12-31
Medline Complete (EBSCOhost) od 2010-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-01-01 do 2017-12-31

Odkazy

PubMed 26342812
DOI 10.1007/s00192-015-2834-2
Knihovny.cz E-zdroje

INTRODUCTION AND HYPOTHESIS: Information on urethral bulking therapy in women after previous pelvic radiotherapy is lacking. This study compared the safety and efficacy of polyacrylamide intraurethral injections in patients with and without previous radiotherapy. METHODS: A total of 46 patients with severe stress urinary incontinence (SUI) were enrolled in this multicenter prospective trial. Group A consisted of 24 patients with previous radiotherapy to the pelvis for the treatment of a gynaecological malignancy. Group B consisted of 22 patients without previous radiotherapy. All patients were treated with a transurethral injection of a bulking solution (Bulkamid). The average follow-up was 12.4 months. The paired Wilcoxon test was used to compare the results before and after the procedure within the groups, and the two-sample Wilcoxon test was used for comparisons between groups. RESULTS: Complete continence was achieved in 25 % of patients in group A and in 36.4 % of patients in group B. Significantly reduced urine leakage was observed in both groups (p = 0.0164 in group A and p = 0.0002 in group B). The total scores in the International Consultation on Incontinence Questionnaire decreased by 5.2 in group A (p = 0.0000) and 6.36 in group B (p = 0.0001). The scores for the Total Patient Perception of Bladder Condition decreased by 1.54 in group A (p = 0.0001) and 2.59 in group B (p = 0.0000), with a significant difference between groups (p = 0.0224). No clinically significant changes in urodynamic parameters were observed. No severe adverse events were noted. CONCLUSIONS: Based on our results, we conclude that urethral bulking therapy is a valuable treatment option in patients with severe SUI who have undergone pelvic radiotherapy for the treatment of gynaecological malignancy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17001022
003      
CZ-PrNML
005      
20181116092755.0
007      
ta
008      
170103s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00192-015-2834-2 $2 doi
024    7_
$a 10.1007/s00192-015-2834-2 $2 doi
035    __
$a (PubMed)26342812
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Krhut, Jan, $u Department of Urology, University Hospital, 17. listopadu 1790, Poruba, 708 52, Ostrava, Czech Republic. jan.krhut@fno.cz. $d 1967- $7 mzk2005309234
245    10
$a Treatment of stress urinary incontinence using polyacrylamide hydrogel in women after radiotherapy: 1-year follow-up / $c J. Krhut, A. Martan, M. Jurakova, D. Nemec, J. Masata, P. Zvara,
520    9_
$a INTRODUCTION AND HYPOTHESIS: Information on urethral bulking therapy in women after previous pelvic radiotherapy is lacking. This study compared the safety and efficacy of polyacrylamide intraurethral injections in patients with and without previous radiotherapy. METHODS: A total of 46 patients with severe stress urinary incontinence (SUI) were enrolled in this multicenter prospective trial. Group A consisted of 24 patients with previous radiotherapy to the pelvis for the treatment of a gynaecological malignancy. Group B consisted of 22 patients without previous radiotherapy. All patients were treated with a transurethral injection of a bulking solution (Bulkamid). The average follow-up was 12.4 months. The paired Wilcoxon test was used to compare the results before and after the procedure within the groups, and the two-sample Wilcoxon test was used for comparisons between groups. RESULTS: Complete continence was achieved in 25 % of patients in group A and in 36.4 % of patients in group B. Significantly reduced urine leakage was observed in both groups (p = 0.0164 in group A and p = 0.0002 in group B). The total scores in the International Consultation on Incontinence Questionnaire decreased by 5.2 in group A (p = 0.0000) and 6.36 in group B (p = 0.0001). The scores for the Total Patient Perception of Bladder Condition decreased by 1.54 in group A (p = 0.0001) and 2.59 in group B (p = 0.0000), with a significant difference between groups (p = 0.0224). No clinically significant changes in urodynamic parameters were observed. No severe adverse events were noted. CONCLUSIONS: Based on our results, we conclude that urethral bulking therapy is a valuable treatment option in patients with severe SUI who have undergone pelvic radiotherapy for the treatment of gynaecological malignancy.
650    _2
$a akrylové pryskyřice $x aplikace a dávkování $x škodlivé účinky $7 D000180
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a biokompatibilní materiály $x aplikace a dávkování $x škodlivé účinky $7 D001672
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a nádory ženských pohlavních orgánů $x komplikace $x radioterapie $7 D005833
650    _2
$a lidé $7 D006801
650    _2
$a hydrogely $x aplikace a dávkování $x škodlivé účinky $7 D020100
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prospektivní studie $7 D011446
650    _2
$a průzkumy a dotazníky $7 D011795
650    _2
$a výsledek terapie $7 D016896
650    _2
$a stresová inkontinence moči $x komplikace $x farmakoterapie $x patofyziologie $7 D014550
655    _2
$a klinické zkoušky kontrolované $7 D018848
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Martan, Alois, $u Department of Obstetrics and Gynecology, 1st Medical Faculty, Charles University and General Faculty Hospital, Prague, Czech Republic. $d 1952- $7 nlk20010103172
700    1_
$a Juráková, Michaela $u Department of Obstetrics and Gynecology, University Hospital, Ostrava, Czech Republic. $7 xx0237497
700    1_
$a Němec, David, $u Department of Urology, University Hospital, 17. listopadu 1790, Poruba, 708 52, Ostrava, Czech Republic. $d 1971- $7 xx0074011
700    1_
$a Mašata, Jaromír, $u Department of Obstetrics and Gynecology, 1st Medical Faculty, Charles University and General Faculty Hospital, Prague, Czech Republic. $d 1969- $7 mzk2004250988
700    1_
$a Zvara, Peter, $u Department of Surgical Studies, Ostrava University, Ostrava, Czech Republic. $d 1962- $7 xx0309569
773    0_
$w MED00002395 $t International urogynecology journal $x 1433-3023 $g Roč. 27, č. 2 (2016), s. 301-305
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26342812 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20181116092844 $b ABA008
999    __
$a ok $b bmc $g 1180162 $s 961589
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 27 $c 2 $d 301-305 $e 20150905 $i 1433-3023 $m International urogynecology journal $n Int. urogynecol. j. (Print) $x MED00002395
GRA    __
$a NT13509 $p MZ0
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace